The immunohistochemistry market in North America region is propelling at an anticipated CAGR of 8.01% during the forecasting years 2018-2026. Demand for quality healthcare backed by increased spending on healthcare act as the primary driver for the growth of immunohistochemistry market in North America region.

NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026

North America Immunohistochemistry Market by Products (Antibodies, Equipment, Reagents, Kits) by Applications (Diagnostics, Testing) by End Users (Hospitals and Diagnostic Laboratories, Research Institutes, Other End-users) & by Geography.

Request free sample

Report Summary

The market of immunohistochemistry in North America region is growing rapidly, making the regional leader in the global market. Increasing autoimmune diseases in the region has increased the expenditure on healthcare. According to Centre for Medicare & Medicaid Services (U.S.), the healthcare expenditure is projected to increase to 20% of the GDP by 2025. Similarly, according to Canadian Institute for Health Information, total health expenditure in Canada was $228 billion in 2016 representing around 11% of the country’s GDP. The United States is leading the region because of the escalating prevalence of autoimmune diseases along with the prevalence of cancer in the country. The rising number of cancer cases has help Canada to be one of the leading countries with cancer, ultimately contributing to the growth of the market in this region.

The key companies in the region are Danaher Corporation, Thermo Fisher Scientific Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ag, Abbott Laboratories, Siemens Ag Healthcare, Biogenex, Bio Sb, Abcam Plc, Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., Perkinelmer, Inc., Histologix, and Merck Millipore.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
RESEARCH METHODOLOGY
- SOURCES OF DATA
  - SECONDARY DATA
  - PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
  - REAGENTS PRODUCTS ARE GROWING AT A SIGNIFICANT RATE
  - DIAGNOSTICS ARE THE MAJORLY USED APPLICATION IN THE MARKET
  - HOSPITALS AND DIAGNOSTIC LABORATORIES HOLDS THE LARGEST MARKET SHARE IN THE END-USERS MARKET

MARKET DETERMINANTS
- MARKET DRIVERS
  - RISING CANCER INCIDENCE
  - TECHNOLOGICAL EXPANSIONS IN IN-VITRO DIAGNOSTIC COMMERCE
  - INCREASING HEALTHCARE SPENDING
  - GROWING POPULARITY OF POC TESTING
- MARKET RESTRAINTS
  - INSURANCE COVERAGE AND REIMBURSEMENT ISSUES
  - LIMITATIONS OF CLOSED SYSTEMS
  - PRESENCE OF AN UNDIAGNOSED POPULATION
- MARKET OPPORTUNITIES
  - USE OF BIOMARKERS FOR DISEASE DIAGNOSIS AND INCREASING EFFICIENCY
  - PARADIGM SHIFT TOWARD PRECISION DIAGNOSIS THROUGH PERSONALIZED MEDICINE
  - ADVANCEMENTS IN TECHNOLOGIES
- MARKET CHALLENGES
  - HIGH INITIAL INVESTMENT AND MAINTENANCE COST
  - STRINGENT REGULATION FOR APPROVAL OF DEVICES
  - PRICING PRESSURE COUPLED WITH LACK OF PRODUCT DIFFERENTIATION

MARKET SEGMENTATION
- MARKET BY PRODUCTS 2018-2026
  - ANTIBODIES
    - PRIMARY ANTIBODIES
    - SECONDARY ANTIBODIES
  - EQUIPMENT
    - SLIDE STAINING SYSTEMS
    - TISSUE MICROARRAYS
    - TISSUE PROCESSING SYSTEMS
    - SLIDE SCANNERS
    - OTHER EQUIPMENT’S
  - REAGENTS
    - HISTOLOGICAL STAINS
    - BLOCKING SERA AND REAGENTS
    - CHROMOGENIC SUBSTRATES
    - FIXATION REAGENTS
    - STABILIZERS
    - ORGANIC SOLVENTS
    - PROTEOLYTIC ENZYMES
    - DILUENTS
  - KITS
- MARKET BY APPLICATIONS 2018-2026
  - DIAGNOSTICS
    - CANCER
    - INFECTIOUS DISEASES
    - CARDIOVASCULAR DISEASE
    - AUTOIMMUNE DISEASES
    - DIABETES MELLITUS
    - NEPHROLOGICAL DISEASES
  - DRUG TESTING
- MARKET BY END-USERS 2018-2026
  - HOSPITALS AND DIAGNOSTIC LABORATORIES
  - RESEARCH INSTITUTES
  - OTHER END-USERS

KEY ANALYTICS
- IMMUNOHISTOCHEMISTRY ETYMOLOGY
- REGULATORY FRAMEWORKS
  - REGULATIONS IN THE UNITED STATES
- VALUE CHAIN ANALYSIS
  - RAW MATERIAL SUPPLIERS
  - MANUFACTURERS
  - DISTRIBUTORS
  - END-USERS
- OPPORTUNITY MATRIX
GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
  - THE UNITED STATES
  - CANADA

COMPANY PROFILES
- ABBOTT LABORATORIES
  - COMPANY PROFILE
  - PRODUCT PORTFOLIO
  - SWOT ANALYSIS
  - STRATEGIC INITIATIVES
- ABCAM PLC
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC INITIATIVES
- AGILENT TECHNOLOGIES, INC.
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
  - SCOT ANALYSIS
  - STRATEGIC INITIATIVES
- BIOGENEX
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC INITIATIVES
- BIO-RAD LABORATORIES, INC.
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
  - SCOT ANALYSIS
  - STRATEGIC INITIATIVE
- BIO SB
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC INITIATIVES
- CELL SIGNALING TECHNOLOGY, INC.
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
  - SCOT ANALYSIS
  - STRATEGIC INITIATIVES
- DANAHER CORPORATION
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
  - SCOT ANALYSIS
  - STRATEGIC INITIATIVES
- HOFFMANN-LA ROCHE AG
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
  - SCOT ANALYSIS
  - STRATEGIC INITIATIVES
- HISTOLOGIX
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
- MERCK MILLIPORE
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
  - STRATEGIC INITIATIVES
- PERKINELMER, INC.
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
  - SCOT ANALYSIS
  - STRATEGIC INITIATIVES
- SIEMENS AG HEALTHCARE
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
  - SWOT ANALYSIS
  - STRATEGIC INITIATIVES
- THERMO FISHER SCIENTIFIC INC.
  - COMPANY OVERVIEW
  - PRODUCT PORTFOLIO
  - SCOT ANALYSIS
  - STRATEGIC INITIATIVES

TABLE LIST

TABLE 1 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT

TABLE 3 POPULATION AGED 60 YEARS AND ABOVE

TABLE 4 POPULATION AGED 80 YEARS AND ABOVE

TABLE 5 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2018-2026 ($ MILLION)

TABLE 6 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2018-2026 ($ MILLION)

TABLE 7 INCIDENCE OF DIABETES IN MAJOR COUNTRIES, 2016 ($ MILLIONS)

TABLE 8 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES -2026 ($ MILLION)

TABLE 9 NORTH AMERICA ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2018-2026 ($ MILLION)

TABLE 10 CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES

TABLE 11 NORTH AMERICA ANTIBODIES MARKET IN SECONDARY ANTIBODIES GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 12 SECONDARY ANTIBODY SELECTION

TABLE 13 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)

TABLE 14 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPE 2018-2026 ($ MILLION)

TABLE 15 NORTH AMERICA EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2018-2026 ($ MILLION)

TABLE 16 NORTH AMERICA EQUIPMENT MARKET IN TISSUE MICROARRAYS 2018-2026 ($ MILLION)

TABLE 17 NORTH AMERICA EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2018-2026 ($ MILLION)

TABLE 18 NORTH AMERICA EQUIPMENT MARKET IN SLIDE SCANNERS 2018-2026 ($ MILLION)

TABLE 19 NORTH AMERICA EQUIPMENT MARKET IN OTHER EQUIPMENT’S 2018-2026 ($ MILLION)

TABLE 20 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)

TABLE 21 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)

TABLE 22 NORTH AMERICA REAGENTS MARKET IN HISTOLOGICAL STAINS 2018-2026 ($ MILLION)

TABLE 23 HISTOLOGY STAINS AND ITS CATEGORIES

TABLE 24 NORTH AMERICA REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2018-2026 ($ MILLION)

TABLE 25 NORTH AMERICA REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2018-2026 ($ MILLION)

TABLE 26 NORTH AMERICA REAGENTS MARKET IN FIXATION REAGENTS 2018-2026 ($ MILLION)

TABLE 27 COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS

TABLE 28 NORTH AMERICA REAGENTS MARKET IN STABILIZERS 2018-2026 ($ MILLION)

TABLE 29 NORTH AMERICA REAGENTS MARKET IN ORGANIC SOLVENTS 2018-2026 ($ MILLION)

TABLE 30 NORTH AMERICA REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2018-2026 ($ MILLION)

TABLE 31 NORTH AMERICA REAGENTS MARKET IN DILUENTS 2018-2026 ($ MILLION)

TABLE 32 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2018-2026 ($ MILLION)

TABLE 33 AVAILABLE KIT COMPONENTS FOR IHC OPTIMIZATION

TABLE 34 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2018-2026 ($ MILLION)

TABLE 35 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)

TABLE 36 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)

TABLE 37 NORTH AMERICA DIAGNOSTIC MARKET IN CANCER 2018-2026 ($ MILLION)

TABLE 38 NORTH AMERICA DIAGNOSTIC MARKET IN INFECTIOUS DISEASES 2018-2026 ($ MILLION)

TABLE 39 NORTH AMERICA DIAGNOSTIC MARKET IN CARDIOVASCULAR DISEASE 2018-2026 ($ MILLION)

TABLE 40 NORTH AMERICA DIAGNOSTIC MARKET IN AUTOIMMUNE DISEASES 2018-2026 ($ MILLION)

TABLE 41 SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES

TABLE 42 NORTH AMERICA DIAGNOSTIC MARKET IN DIABETES MELLITUS 2018-2026 ($ MILLION)

TABLE 43 NORTH AMERICA DIAGNOSTIC MARKET IN NEPHROLOGICAL DISEASES 2018-2026 ($ MILLION)

TABLE 44 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2018-2026 ($ MILLION)

TABLE 45 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2018-2026 ($ MILLION)

TABLE 46 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2018-2026 ($ MILLION)

TABLE 47 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2018-2026 ($ MILLION)

TABLE 48 CANCER RESEARCH PROGRAM

TABLE 49 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2018-2026 ($ MILLION)

TABLE 50 IMMUNOHISTOCHEMISTRY USAGE IN FORENSIC PATHOLOGY

TABLE 51 ANTIBODIES MANUFACTURERS IN THE NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET

TABLE 52 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

TABLE 53 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

TABLE 54 FUND INVESTED FOR DIFFERENT CANCER TYPES (2017)

TABLE 55 PERCENT DISTRIBUTION OF PROJECTED NEW CANCER CASES (2017)

FIGURE LIST

FIGURE 1 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 2 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2018-2026 ($ MILLION)

FIGURE 3 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)

FIGURE 4 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)

FIGURE 5 PHASES OF HISTOLOGICAL STAINING

FIGURE 6 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2018-2026 ($ MILLION)

FIGURE 7 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)

FIGURE 8 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2018-2026 ($ MILLION)

FIGURE 9 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2018-2026 ($ MILLION)

FIGURE 10 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2018-2026 ($ MILLION)

FIGURE 11 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2018-2026 ($ MILLION)

FIGURE 12 HISTORY OF IMMUNOHISTOCHEMISTRY

FIGURE 13 NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 14 THE UNITED STATES IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 15 CANADA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

Segmentation

GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
  - THE UNITED STATES
  - CANADA

MARKET SEGMENTATION
- MARKET BY PRODUCTS 2018-2026
  - ANTIBODIES
    - PRIMARY ANTIBODIES
    - SECONDARY ANTIBODIES
  - EQUIPMENT
    - SLIDE STAINING SYSTEMS
    - TISSUE MICROARRAYS
    - TISSUE PROCESSING SYSTEMS
    - SLIDE SCANNERS
    - OTHER EQUIPMENT’S
  - REAGENTS
    - HISTOLOGICAL STAINS
    - BLOCKING SERA AND REAGENTS
    - CHROMOGENIC SUBSTRATES
    - FIXATION REAGENTS
    - STABILIZERS
    - ORGANIC SOLVENTS
    - PROTEOLYTIC ENZYMES
    - DILUENTS
  - KITS
- MARKET BY APPLICATIONS 2018-2026
  - DIAGNOSTICS
    - CANCER
    - INFECTIOUS DISEASES
    - CARDIOVASCULAR DISEASE
    - AUTOIMMUNE DISEASES
    - DIABETES MELLITUS
    - NEPHROLOGICAL DISEASES
  - DRUG TESTING
- MARKET BY END-USERS 2018-2026
  - HOSPITALS AND DIAGNOSTIC LABORATORIES
  - RESEARCH INSTITUTES
  - OTHER END-USERS